TNFSF10 and cancer: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising anti-cancer agent because of its capability to induce apoptosis in various cancer cell types, but with negligible cytotoxic effects in normal cells (Mongkolsapaya et al., 1998).